Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2011:3:61-8.
doi: 10.2147/HIV.S18667. Epub 2011 Jul 1.

Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience

Jordan E Lake  1 , Ruth K Friedman, Cynthia B Cunha, Sandra W Cardoso, Valdilea G Veloso, Judith S Currier, Beatriz Grinsztejn
Affiliations

Participation of women in HIV clinical trials: the IPEC-FIOCRUZ experience

Jordan E Lake et al. HIV AIDS (Auckl). 2011.

Abstract

Background: Fifty percent of people living with human immunodeficiency virus (HIV) or acquired immunodeficiency syndrome (AIDS) worldwide are female. In Brazil, for example, 240,000 women are infected with HIV, rates of infection in women have increased over the last two decades, and addressing HIV prevention and treatment for women at risk for, or living with, HIV/AIDS remains a challenge. To better address the needs of women living with HIV in Brazil, the Instituto de Pesquisa Clínica Evandro Chagas - Fundação Oswaldo Cruz (IPEC-FIOCRUZ) HIV Women's Cohort was established in 1996 to study the natural history of women seeking HIV care. This analysis describes the characteristics of women in the cohort who participated in HIV clinical trials between 1999 and 2008.

Methods: A total of 736 Women's Cohort participants were in active follow-up and 665 participants from the Women's Cohort were included in univariable and multivariable analyses to determine socioeconomic and sociodemographic factors associated with women's participation in HIV clinical trials at our site.

Results: Of the complete cohort, 23% participated in a clinical trial between January 1999 and July 2008. Odds of participation decreased for women who were younger than 35 years old, currently employed, had an HIV-positive sexual partner, and/or who reported a lifetime history of illicit drug use. Alternatively, the odds of participation increased for women who had more than 8 years of formal education, were living independently, and/or were married or cohabitating.

Conclusion: The rate of participation in HIV clinical trials by women in the IPEC-Fiocruz Cohort was similar to other published cohorts, but identification of local risk factors and barriers to participation remains important. Our analysis offers a novel description of the factors associated with participation in HIV clinical trials among women in care at IPEC-FIOCRUZ in Rio de Janeiro, Brazil.

Keywords: AIDS; Brazil; South America; clinical trial participation.

PubMed Disclaimer

Figures

Figure 1
Figure 1
IPEC-FIOCRUZ (Instituto de Pesquisa Clínica Evandro Chagas – Fundação Oswaldo Cruz) Women’s Cohort: screening and participation in clinical trials. Rio de Janeiro, Brazil, 1999–2008.
See this image and copyright information in PMC

References

    1. UNAIDS. Global Report: UNAIDS Report on the Global Aids Epidemic 2010. UNAIDS; 2010.
    1. UNAIDS. Epidemiological Fact Sheet on HIV/AIDS. UNAIDS; 2008.
    1. Villela W, Kraiczyk J. Integrated Plan to Combat the Feminization of the AIDS Epidemic and Other STDs: an Analysis Two Years After Launching. Unifesp; 2007.
    1. Health Surveillance Secretariat, STD, AIDS and Viral Hepatitis Department, Brazilian Ministry of Health. Targets and Commitments Made by Member-states at the United Nations General Assembly Special Session on HIV/AIDS. Brazilian Ministry of Health; 2010.
    1. Grinsztejn B, Bastos FI, Veloso VG, et al. Assessing sexually transmitted infections in a cohort of women living with HIV/AIDS, in Rio de Janeiro, Brazil. Int J STD AIDS. 2006;17(7):473–478. - PubMed